ACAD logo

ACADIA Pharmaceuticals (ACAD) Revenue

Annual revenue:

$957.80M+$231.36M(+31.85%)
December 31, 2024

Summary

  • As of today (May 18, 2025), ACAD annual revenue is $957.80 million, with the most recent change of +$231.36 million (+31.85%) on December 31, 2024.
  • During the last 3 years, ACAD annual revenue has risen by +$473.65 million (+97.83%).
  • ACAD annual revenue is now at all-time high.

Performance

ACAD Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

Quarterly revenue:

$244.32M-$15.29M(-5.89%)
March 31, 2025

Summary

  • As of today (May 18, 2025), ACAD quarterly revenue is $244.32 million, with the most recent change of -$15.29 million (-5.89%) on March 31, 2025.
  • Over the past year, ACAD quarterly revenue has increased by +$38.49 million (+18.70%).
  • ACAD quarterly revenue is now -5.89% below its all-time high of $259.60 million, reached on December 31, 2024.

Performance

ACAD Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

TTM revenue:

$996.28M+$38.49M(+4.02%)
March 31, 2025

Summary

  • As of today (May 18, 2025), ACAD TTM revenue is $996.28 million, with the most recent change of +$38.49 million (+4.02%) on March 31, 2025.
  • Over the past year, ACAD TTM revenue has increased by +$182.48 million (+22.42%).
  • ACAD TTM revenue is now at all-time high.

Performance

ACAD TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

ACAD Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+31.9%+18.7%+22.4%
3 y3 years+97.8%+111.6%+102.1%
5 y5 years+182.5%+171.3%+172.1%

ACAD Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+97.8%-5.9%+111.6%at high+102.1%
5 y5-yearat high+182.5%-5.9%+171.3%at high+172.1%
alltimeall timeat high>+9999.0%-5.9%>+9999.0%at high>+9999.0%

ACAD Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$244.32M(-5.9%)
$996.28M(+4.0%)
Dec 2024
$957.80M(+31.8%)
$259.60M(+3.7%)
$957.80M(+3.1%)
Sep 2024
-
$250.40M(+3.5%)
$929.24M(+4.3%)
Jun 2024
-
$241.96M(+17.6%)
$890.53M(+9.4%)
Mar 2024
-
$205.83M(-10.9%)
$813.81M(+12.0%)
Dec 2023
$726.44M(+40.4%)
$231.04M(+9.1%)
$726.44M(+15.0%)
Sep 2023
-
$211.70M(+28.1%)
$631.89M(+14.7%)
Jun 2023
-
$165.24M(+39.5%)
$550.90M(+5.9%)
Mar 2023
-
$118.46M(-13.2%)
$520.23M(+0.6%)
Dec 2022
$517.24M(+6.8%)
$136.49M(+4.4%)
$517.24M(+1.1%)
Sep 2022
-
$130.71M(-2.9%)
$511.50M(-0.2%)
Jun 2022
-
$134.56M(+16.5%)
$512.40M(+3.9%)
Mar 2022
-
$115.47M(-11.7%)
$493.06M(+1.8%)
Dec 2021
$484.14M(+9.6%)
$130.76M(-0.6%)
$484.14M(+2.1%)
Sep 2021
-
$131.61M(+14.2%)
$474.39M(+2.4%)
Jun 2021
-
$115.22M(+8.1%)
$463.36M(+1.1%)
Mar 2021
-
$106.55M(-11.9%)
$458.24M(+3.7%)
Dec 2020
$441.75M(+30.3%)
$121.01M(+0.4%)
$441.75M(+5.4%)
Sep 2020
-
$120.58M(+9.5%)
$419.07M(+6.6%)
Jun 2020
-
$110.10M(+22.2%)
$393.08M(+7.3%)
Mar 2020
-
$90.07M(-8.4%)
$366.19M(+8.0%)
Dec 2019
$339.08M(+51.5%)
$98.33M(+4.0%)
$339.08M(+12.9%)
Sep 2019
-
$94.59M(+13.7%)
$300.32M(+13.7%)
Jun 2019
-
$83.20M(+32.2%)
$264.04M(+11.0%)
Mar 2019
-
$62.96M(+5.7%)
$237.90M(+6.3%)
Dec 2018
$223.81M(+79.2%)
$59.57M(+2.2%)
$223.81M(+7.7%)
Sep 2018
-
$58.30M(+2.2%)
$207.80M(+12.3%)
Jun 2018
-
$57.06M(+16.8%)
$185.07M(+16.8%)
Mar 2018
-
$48.87M(+12.2%)
$158.48M(+26.9%)
Dec 2017
$124.90M(+620.7%)
$43.56M(+22.4%)
$124.90M(+33.9%)
Sep 2017
-
$35.58M(+16.7%)
$93.30M(+48.1%)
Jun 2017
-
$30.48M(+99.4%)
$62.99M(+93.1%)
Mar 2017
-
$15.29M(+27.8%)
$32.61M(+88.2%)
Dec 2016
$17.33M(>+9900.0%)
$11.96M(+127.1%)
$17.33M(+221.8%)
Sep 2016
-
$5.27M(+5330.9%)
$5.39M(+3330.6%)
Jun 2016
-
$97.00K(+2325.0%)
$157.00K(+157.4%)
Mar 2016
-
$4000.00(-76.5%)
$61.00K(0.0%)
Dec 2015
$61.00K(-49.2%)
$17.00K(-56.4%)
$61.00K(-33.7%)
Sep 2015
-
$39.00K(+3800.0%)
$92.00K(+35.3%)
Jun 2015
-
$1000.00(-75.0%)
$68.00K(-28.4%)
Mar 2015
-
$4000.00(-91.7%)
$95.00K(-21.5%)
Dec 2014
$120.00K(-89.5%)
$48.00K(+220.0%)
$121.00K(+10.0%)
Sep 2014
-
$15.00K(-46.4%)
$110.00K(-67.2%)
Jun 2014
-
$28.00K(-6.7%)
$335.00K(-55.8%)
Mar 2014
-
$30.00K(-18.9%)
$758.00K(-33.8%)
Dec 2013
$1.15M
$37.00K(-84.6%)
$1.15M(-23.1%)
DateAnnualQuarterlyTTM
Sep 2013
-
$240.00K(-46.8%)
$1.49M(-68.5%)
Jun 2013
-
$451.00K(+8.2%)
$4.73M(-3.0%)
Mar 2013
-
$417.00K(+9.7%)
$4.87M(-0.7%)
Dec 2012
$4.91M(+137.4%)
$380.00K(-89.1%)
$4.91M(-4.1%)
Sep 2012
-
$3.48M(+480.6%)
$5.12M(+130.3%)
Jun 2012
-
$599.00K(+33.1%)
$2.22M(+6.7%)
Mar 2012
-
$450.00K(-23.5%)
$2.08M(+0.7%)
Dec 2011
$2.07M(-95.1%)
$588.00K(+0.7%)
$2.07M(-94.4%)
Sep 2011
-
$584.00K(+27.0%)
$36.88M(-4.4%)
Jun 2011
-
$460.00K(+5.7%)
$38.60M(-4.5%)
Mar 2011
-
$435.00K(-98.8%)
$40.44M(-4.0%)
Dec 2010
$42.13M(+558.5%)
$35.40M(+1438.6%)
$42.13M(+395.7%)
Sep 2010
-
$2.30M(+0.2%)
$8.50M(-1.6%)
Jun 2010
-
$2.30M(+7.7%)
$8.63M(+5.8%)
Mar 2010
-
$2.13M(+20.6%)
$8.16M(+27.5%)
Dec 2009
$6.40M(+302.5%)
$1.77M(-27.4%)
$6.40M(+29.1%)
Sep 2009
-
$2.44M(+33.8%)
$4.95M(+76.9%)
Jun 2009
-
$1.82M(+386.6%)
$2.80M(+141.9%)
Mar 2009
-
$374.00K(+15.1%)
$1.16M(-27.2%)
Dec 2008
$1.59M(-79.0%)
$325.00K(+15.2%)
$1.59M(-44.2%)
Sep 2008
-
$282.00K(+59.3%)
$2.85M(-37.0%)
Jun 2008
-
$177.00K(-78.0%)
$4.52M(-29.3%)
Mar 2008
-
$806.00K(-49.1%)
$6.40M(-15.3%)
Dec 2007
$7.55M(-7.1%)
$1.58M(-19.1%)
$7.55M(-2.5%)
Sep 2007
-
$1.96M(-4.8%)
$7.75M(+0.2%)
Jun 2007
-
$2.06M(+4.8%)
$7.73M(+2.3%)
Mar 2007
-
$1.96M(+10.5%)
$7.56M(-7.1%)
Dec 2006
$8.13M(-25.8%)
$1.77M(-8.7%)
$8.13M(-7.6%)
Sep 2006
-
$1.94M(+3.3%)
$8.80M(-16.4%)
Jun 2006
-
$1.88M(-25.9%)
$10.53M(-5.7%)
Mar 2006
-
$2.54M(+3.8%)
$11.17M(+1.9%)
Dec 2005
$10.96M(+138.0%)
$2.44M(-33.5%)
$10.96M(+14.2%)
Sep 2005
-
$3.67M(+46.0%)
$9.60M(+27.9%)
Jun 2005
-
$2.52M(+8.2%)
$7.50M(+25.0%)
Mar 2005
-
$2.33M(+114.7%)
$6.01M(+30.4%)
Dec 2004
$4.60M(-37.6%)
$1.08M(-31.5%)
$4.60M(-14.2%)
Sep 2004
-
$1.58M(+55.7%)
$5.37M(-4.7%)
Jun 2004
-
$1.02M(+9.9%)
$5.63M(-18.4%)
Mar 2004
-
$923.90K(-49.9%)
$6.89M(-11.8%)
Dec 2003
$7.38M(+17.6%)
$1.84M(0.0%)
$7.82M(+30.9%)
Sep 2003
-
$1.84M(-19.1%)
$5.98M(+44.7%)
Jun 2003
-
$2.28M(+23.3%)
$4.13M(+123.3%)
Mar 2003
-
$1.85M
$1.85M
Dec 2002
$6.28M(+69.0%)
-
-
Dec 2001
$3.71M(-13.9%)
-
-
Dec 2000
$4.31M
-
-

FAQ

  • What is ACADIA Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual revenue year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?
  • What is ACADIA Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals TTM revenue year-on-year change?

What is ACADIA Pharmaceuticals annual revenue?

The current annual revenue of ACAD is $957.80M

What is the all time high annual revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual revenue is $957.80M

What is ACADIA Pharmaceuticals annual revenue year-on-year change?

Over the past year, ACAD annual revenue has changed by +$231.36M (+31.85%)

What is ACADIA Pharmaceuticals quarterly revenue?

The current quarterly revenue of ACAD is $244.32M

What is the all time high quarterly revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly revenue is $259.60M

What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, ACAD quarterly revenue has changed by +$38.49M (+18.70%)

What is ACADIA Pharmaceuticals TTM revenue?

The current TTM revenue of ACAD is $996.28M

What is the all time high TTM revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high TTM revenue is $996.28M

What is ACADIA Pharmaceuticals TTM revenue year-on-year change?

Over the past year, ACAD TTM revenue has changed by +$182.48M (+22.42%)
On this page